share_log

Teva Pharmaceutical Industries | 10-K: FY2022 Annual Report

SEC ·  Feb 10, 2023 20:02
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.